This company has been marked as potentially delisted and may not be actively trading. Enhabit (EHAB) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsInsider TradesNews and TrendsOwnership Get the Latest News and Ratings for EHAB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Enhabit and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EHAB Analyst Ratings Over TimeTypeCurrent Forecast10/24/25 to 10/24/261 Month Ago9/24/25 to 9/24/263 Months Ago7/26/25 to 7/26/261 Year Ago10/24/24 to 10/24/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy2 Buy rating(s)2 Buy rating(s)2 Buy rating(s)1 Buy rating(s)Hold6 Hold rating(s)6 Hold rating(s)6 Hold rating(s)2 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)Consensus Price Target$13.57$13.57$13.57$8.67Forecasted Upside-1.66% Downside-1.66% Downside-1.66% Downside1.42% UpsideConsensus RatingHoldHoldHoldHold EHAB Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History EHAB Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Enhabit Stock vs. The CompetitionTypeEnhabitHealthcare CompaniesBroader MarketConsensus Rating Score 2.11 2.32 2.53Consensus RatingHoldHoldModerate BuyPredicted Upside-1.66% Downside1,400.11% Upside16.91% UpsideNews Sentiment RatingNeutral NewsSee Recent EHAB NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/24/2024 - 10/24/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails4/14/2026 Weiss Ratings3 of 5 stars Reiterated RatingSell (D-)3/6/2026 TD Cowen3 of 5 starsRyan LangstonNot RatedReiterated RatingBuy ➝ Hold$12.00 ➝ $13.80+1.40%2/24/2026 UBS Group4 of 5 starsA.J. Rice4 of 5 starsReiterated RatingHold ➝ Neutral$12.00 ➝ $13.80+1.46%2/23/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsBrian TanquilutSubscribe to MarketBeat All Access to unlock analyst rankingsDowngradeBuy ➝ Hold$12.50 ➝ $13.80+1.58%2/23/2026 Leerink PartnersSubscribe to MarketBeat All Access to unlock brokerage rankingsWhit MayoSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetMarket Perform$9.50 ➝ $13.80+1.51%2/23/2026 Truist FinancialSubscribe to MarketBeat All Access to unlock brokerage rankings Set Target$13.80+1.51%2/23/2026 OppenheimerSubscribe to MarketBeat All Access to unlock brokerage rankingsMichael WiederhornSubscribe to MarketBeat All Access to unlock analyst rankingsDowngradeOutperform ➝ Market Perform1/13/2026 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access to unlock brokerage rankings UpgradeBuy1/8/2026 Wolfe ResearchSubscribe to MarketBeat All Access to unlock brokerage rankings Set Target$12.00+26.22%12/16/2025 CitigroupSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingBuy Get the Latest News and Ratings for EHAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter. Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:05 PM ET. EHAB Forecast - Frequently Asked Questions What is Enhabit's forecast for 2026? According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Enhabit is $13.57, with a high forecast of $14.00 and a low forecast of $12.00. Should I buy or sell Enhabit stock right now? 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enhabit in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" EHAB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EHAB, but not buy additional shares or sell existing shares. Does Enhabit's stock price have much downside? According to analysts, Enhabit's stock has a predicted downside of -1.66% based on their 12-month stock forecasts. Do Wall Street analysts like Enhabit more than its competitors? Analysts like Enhabit less than other "healthcare" companies. The consensus rating score for Enhabit is 2.11 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how EHAB compares to other companies. Stock Forecasts and Research Tools Related Companies Acadia Healthcare Stock Forecast Privia Health Group Stock Forecast Aveanna Healthcare Stock Forecast Clover Health Investments Stock Forecast Brookdale Senior Living Stock Forecast Pediatrix Medical Group Stock Forecast Addus HomeCare Stock Forecast Progyny Stock Forecast Astrana Health Stock Forecast NeoGenomics Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Enhabit RecommendationsWeiss RatingsTD CowenUBS GroupTruist FinancialOppenheimerLeerink PartnersJefferies Financial GroupDeutsche Bank AktiengesellschaftWolfe ResearchCitigroup MarketBeat monitors more than a dozen sources for Enhabit analyst ratings, with the most recent rating issued on 4/14/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredYou haven't downloaded this yetBill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredSpaceX is worth trillions. This one's $14.It is not SpaceX, Tesla, Starlink, or Neuralink. But Elon's rocket company shows up in this stock's paperwork,...Behind the Markets | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
